论文部分内容阅读
链霉素的出现结核病的历史,可称是一部日本的近代史,是从1945年战败后开始的新的历史。可以说是从全力以赴地同结核菌搏斗的时代,开始进入了在相当可靠的防治规划基础上,能够完全对付结核菌的新时期。1944年链霉素(SM)的发现,在人类历史上具有重大意义。如果把洒尔佛散(1920年)作为例外,可以说现代化学疗法是从磺胺类制剂(1933年)、青霉素(1929年)开始的。SM当然是以后的产物。对于结核病这种严重的慢性感染症,尽管科学家们热心探索,也没找到有效药物。同样是感染性疾病,可能只有结核病例外,这种失望不仅居民而且在专家中也较普遍,可是SM终于在此时出现了。
The emergence of streptomycin The history of tuberculosis can be described as a modern history in Japan, is a new history since the defeat in 1945. It can be said that from the era of full struggle with M. tuberculosis, it has begun to enter a fairly reliable prevention and control program and can completely deal with the new era of TB. The discovery of streptomycin (SM) in 1944 was of great significance in human history. With the exception of Sallog Powder (1920), modern chemotherapeutics can be said to start with the sulfonamides (1933) and penicillin (1929). SM is of course the product of the future. For a serious chronic infection such as tuberculosis, no effective medicine was found despite the enthusiastic exploration by scientists. The same is an infectious disease, may only be the exception of tuberculosis, this disappointment not only residents but also more common among experts, but SM finally appeared at this time.